Related Experiment Video
Updated: Feb 28, 2026
08:07
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
10.7K
Identification of the Novel HLA-B*57:205 Allele by Next-Generation Sequencing
Ruby J Siegel1, Katrin Hacke1, Rose M Ridgley1
1Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona, USA.
HLA
|February 27, 2026
Summary
Human Leukocyte Antigen (HLA) B*57:205 is a newly identified allele. It differs from the common HLA-B*57:01:01:01 by a single nucleotide substitution in Exon 1.
Area of Science:
- Immunogenetics
- Molecular biology
- Human Leukocyte Antigen (HLA) system
Background:
- The HLA-B locus plays a critical role in immune responses.
- Allelic variations within HLA genes contribute to diverse immune capabilities and disease susceptibilities.
- Specific HLA-B alleles are associated with differential control of viral infections, such as HIV.
Purpose of the Study:
- To characterize a novel HLA-B allele, designated HLA-B*57:205.
- To identify the specific genetic differences between HLA-B*57:205 and a well-characterized related allele, HLA-B*57:01:01:01.
Main Methods:
- Nucleotide sequencing of the HLA-B gene.
- Comparative sequence analysis to identify variations.
- Bioinformatic analysis of genetic data.
Main Results:
- HLA-B*57:205 was identified as a distinct allele within the HLA-B*57 family.
- A single nucleotide substitution was detected in Exon 1 of HLA-B*57:205 when compared to HLA-B*57:01:01:01.
- This substitution represents the sole genetic difference between these two alleles.
Conclusions:
- HLA-B*57:205 represents a novel genetic variant within the HLA-B*57 supertype.
- The identified nucleotide substitution in Exon 1 is the defining characteristic of HLA-B*57:205.
- Further studies are warranted to investigate the potential immunological or clinical implications of this new allele.
Related Concept Videos
03:00Next-generation Sequencing
99.5K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
99.5K
01:11Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K